Intuitive Surgical (ISRG) Liabilities and Shareholders Equity (2009 - 2026)
Intuitive Surgical (ISRG) posted Liabilities and Shareholders Equity of $20.9 billion for Q2 2026, up 3.81% on a QoQ basis from $20.1 billion in Q1 2026, and up 3.54% year-over-year from $20.2 billion in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $20.9 billion in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 3.54% year-over-year to $20.9 billion in Q2 2026; TTM through Jun 2026 was $80.8 billion, a 6.5% increase from a year earlier, with the FY2025 full-year figure at $20.5 billion, up 9.15% from the prior year.
- Liabilities and Shareholders Equity was $20.9 billion for Q2 2026 at Intuitive Surgical, up from $20.1 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $20.9 billion in Q2 2026, with the low at $13.0 billion in Q4 2022.
- Average Liabilities and Shareholders Equity over 5 years is $16.7 billion, with a median of $16.2 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity dropped 4.57% in 2023, then advanced 21.43% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $13.0 billion in 2022, then grew by 19.02% to $15.4 billion in 2023, then grew by 21.38% to $18.7 billion in 2024, then climbed by 9.15% to $20.5 billion in 2025, then climbed by 2.04% to $20.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $20.9 billion (Q2 2026), $20.1 billion (Q1 2026), and $20.5 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 17.73 Bn | 17.32 Bn | 1.54 Bn | 22.80 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.88 Bn |
| Mar 31, 2026 | 20.11 Bn |
| Dec 31, 2025 | 20.46 Bn |
| Sep 30, 2025 | 19.35 Bn |
| Jun 30, 2025 | 20.16 Bn |
| Mar 31, 2025 | 19.22 Bn |
| Dec 31, 2024 | 18.74 Bn |
| Sep 30, 2024 | 17.74 Bn |
| Jun 30, 2024 | 16.65 Bn |
| Mar 31, 2024 | 15.83 Bn |
| Dec 31, 2023 | 15.44 Bn |
| Sep 30, 2023 | 14.71 Bn |
| Jun 30, 2023 | 13.90 Bn |
| Mar 31, 2023 | 13.05 Bn |
| Dec 31, 2022 | 12.97 Bn |
| Sep 30, 2022 | 13.26 Bn |
| Jun 30, 2022 | 13.71 Bn |
| Mar 31, 2022 | 13.68 Bn |
| Dec 31, 2021 | 13.56 Bn |
| Sep 30, 2021 | 12.93 Bn |